Locally Advanced or Metastatic HER2-Expressing Cancers Clinical Trials in Melbourne, Victoria

To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers